Taiho Oncology, Inc.

This study is testing whether adding a new drug called zipalertinib to standard chemotherapy after lung cancer surgery works better than chemotherapy alone. It's for people with early-stage lung cancer who have specific, less common genetic changes in their tumor. The goal is to …

This study is testing an oral drug called zipalertinib for adults with advanced non-small cell lung cancer that has specific genetic changes (EGFR mutations, including exon 20 insertions). The main goals are to see if the drug safely shrinks tumors and controls the cancer. It wil…

This study is testing a new oral pill called ASTX030 for people with certain blood cancers like acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The main goal is to see if the pill works as well as or better than the standard injected medication. It will also tes…

This study is testing two different daily doses of an oral drug called futibatinib for people with advanced bile duct cancer (cholangiocarcinoma) that has a specific genetic change called an FGFR2 fusion or rearrangement. The goal is to see if a lower dose (16 mg) is as safe and …

This early-stage study aims to understand how a cancer drug is processed by the body in patients with moderate to severe liver problems. It will enroll about 27 adults with certain blood cancers or solid tumors to measure drug levels and check for side effects. The main goal is t…

This early-stage study aims to understand how a combination cancer pill is processed by the body in patients with severe kidney problems compared to those with normal kidney function. It will enroll about 18 adults with certain blood cancers or solid tumors who could benefit from…